Interest in {dimethyltryptamine | copyright | this substance ) is increasingly generating a significant dialogue across Canada. Previously considered the fringes of study , copyright is now receiving greater scrutiny from researchers , clinicians, and the population . Legislative guidelines surrounding its possible use – particularly in therapeut